These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9489527)

  • 21. Sensitive measures of executive dysfunction in non-demented Parkinson's disease.
    Bott NT; Johnson ET; Schuff N; Galifianakis N; Subas T; Pollock J; Pressman P; Kramer JH; Possin KL
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1430-3. PubMed ID: 25454318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological impairment in Parkinson's disease with and without depression.
    Tröster AI; Stalp LD; Paolo AM; Fields JA; Koller WC
    Arch Neurol; 1995 Dec; 52(12):1164-9. PubMed ID: 7492290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Lundin KF; Edström M; Forsgren L
    Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease].
    Gui XH; Wang LP; Wu CL; Sun XF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1664-7. PubMed ID: 27290706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairments in progression of Parkinson's disease.
    Stepkina DA; Zakharov VV; Yakhno NN
    Neurosci Behav Physiol; 2010 Jan; 40(1):61-7. PubMed ID: 20012495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
    Hobson P; Meara J
    Mov Disord; 2004 Sep; 19(9):1043-9. PubMed ID: 15372593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Mar; 17(2):250-7. PubMed ID: 11921109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early impairment of cognitive functions in Parkinson's disease.
    Stella F; Gobbi LT; Gobbi S; Oliani MM; Tanaka K; Pieruccini-Faria F
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):406-10. PubMed ID: 17665005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
    Verbaan D; Jeukens-Visser M; Van Laar T; van Rooden SM; Van Zwet EW; Marinus J; van Hilten JJ
    Mov Disord; 2011 Aug; 26(10):1881-6. PubMed ID: 21542025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuropsychological impairment in Parkinson's disease without dementia].
    Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
    Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropsychological characteristics of Parkinson's disease].
    Ostrosky-Solis F
    Rev Neurol; 2000 Apr 16-30; 30(8):788-96. PubMed ID: 10893746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of cognitive abilities on driving in people with Parkinson's disease.
    Radford K; Lincoln N; Lennox G
    Disabil Rehabil; 2004 Jan; 26(2):65-70. PubMed ID: 14668141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
    Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
    Estanga A; Rodriguez-Oroz MC; Ruiz-Martinez J; Barandiaran M; Gorostidi A; Bergareche A; Mondragon E; Lopez de Munain A; Marti-Masso JF
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1097-100. PubMed ID: 25127457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.